Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1590 Inhibitors

Olr1590 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the Olr1590 receptor, a member of the olfactory receptor family within the extensive G-protein coupled receptor (GPCR) superfamily. These olfactory receptors, including Olr1590, are integral to the detection and transduction of odorant molecules, playing a critical role in the olfactory system's ability to process chemical signals and translate them into sensory perceptions. The Olr1590 receptor functions by binding to specific odorant ligands, which initiates a cascade of intracellular signaling events that ultimately result in the activation of neural pathways responsible for the perception of different smells. Olr1590 inhibitors are designed to disrupt this signaling process by binding to the receptor in a manner that blocks its interaction with natural ligands, thereby preventing the receptor from activating its normal signaling pathways. This inhibition can occur through direct competition at the receptor's active site, where the odorant molecules would typically bind, or through interaction with allosteric sites, inducing conformational changes that reduce the receptor's functional activity.

The development of Olr1590 inhibitors involves a comprehensive and systematic approach to optimizing their chemical properties, such as binding affinity, selectivity, and stability. Researchers often utilize molecular modeling and docking simulations to predict how these inhibitors will interact with the Olr1590 receptor, providing insights into the receptor's structure and identifying potential binding sites. High-throughput screening of chemical libraries is another crucial step in identifying lead compounds that exhibit promising inhibitory effects on Olr1590. Once these lead compounds are identified, they undergo structure-activity relationship (SAR) studies to refine their chemical structures, enhancing their potency, selectivity, and overall stability while minimizing off-target effects. This refinement process may involve modifying the core chemical scaffold or altering functional groups to improve the interactions with the receptor. Additionally, considerations such as solubility, lipophilicity, and metabolic stability are carefully evaluated to ensure that these inhibitors can function effectively in various physiological environments. Through this meticulous development process, Olr1590 inhibitors contribute to a deeper understanding of the molecular mechanisms underlying olfactory receptor function and advance the broader field of GPCR-mediated signal transduction, offering valuable insights into the complex processes that govern sensory perception and cellular communication.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Allopurinol

315-30-0sc-207272
25 g
$131.00
(0)

Xanthine oxidase inhibitor, can indirectly modulate cellular processes related to Olr1590.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$79.00
$416.00
1
(1)

Beta-1 adrenergic receptor antagonist, might influence signaling pathways indirectly affecting Olr1590.

Clopidogrel

113665-84-2sc-507403
1 g
$122.00
1
(0)

Antiplatelet agent, could alter signaling pathways indirectly, impacting Olr1590.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid, may influence cellular processes indirectly related to Olr1590 function.

Ezetimibe

163222-33-1sc-205690
sc-205690A
25 mg
100 mg
$96.00
$241.00
12
(2)

Cholesterol absorption inhibitor, can affect signaling pathways indirectly impacting Olr1590.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Antidiabetic agent, could affect cellular metabolism indirectly impacting Olr1590.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

Proton pump inhibitor, may influence gastric-related signaling indirectly impacting Olr1590.

Rosuvastatin

287714-41-4sc-481834
10 mg
$145.00
8
(0)

Statin, can modulate cholesterol pathways indirectly affecting Olr1590.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$40.00
$92.00
$122.00
4
(1)

Angiotensin II receptor antagonist, could affect signaling pathways indirectly related to Olr1590.

Warfarin

81-81-2sc-205888
sc-205888A
1 g
10 g
$73.00
$246.00
7
(1)

Anticoagulant, may modulate blood coagulation pathways indirectly impacting Olr1590.